230 related articles for article (PubMed ID: 11032905)
1. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations.
Goedert M; Satumtira S; Jakes R; Smith MJ; Kamibayashi C; White CL; Sontag E
J Neurochem; 2000 Nov; 75(5):2155-62. PubMed ID: 11032905
[TBL] [Abstract][Full Text] [Related]
2. Missense point mutations of tau to segregate with FTDP-17 exhibit site-specific effects on microtubule structure in COS cells: a novel action of R406W mutation.
Sahara N; Tomiyama T; Mori H
J Neurosci Res; 2000 May; 60(3):380-7. PubMed ID: 10797541
[TBL] [Abstract][Full Text] [Related]
3. FTDP-17 missense mutations site-specifically inhibit as well as promote dephosphorylation of microtubule-associated protein tau by protein phosphatases of HEK-293 cell extract.
Han D; Paudel HK
Neurochem Int; 2009 Jan; 54(1):14-27. PubMed ID: 18992292
[TBL] [Abstract][Full Text] [Related]
4. Frontotemporal dementia with Parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation.
Maeda S; Sato Y; Takashima A
Neurobiol Aging; 2018 Sep; 69():26-32. PubMed ID: 29852407
[TBL] [Abstract][Full Text] [Related]
5. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Spillantini MG; Van Swieten JC; Goedert M
Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
[TBL] [Abstract][Full Text] [Related]
6. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly.
Hasegawa M; Smith MJ; Goedert M
FEBS Lett; 1998 Oct; 437(3):207-10. PubMed ID: 9824291
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Kowalska A
Folia Neuropathol; 2002; 40(3):111-8. PubMed ID: 12572916
[TBL] [Abstract][Full Text] [Related]
8. Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions.
DeTure M; Ko LW; Yen S; Nacharaju P; Easson C; Lewis J; van Slegtenhorst M; Hutton M; Yen SH
Brain Res; 2000 Jan; 853(1):5-14. PubMed ID: 10627302
[TBL] [Abstract][Full Text] [Related]
9. FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion.
Yen S; Easson C; Nacharaju P; Hutton M; Yen SH
FEBS Lett; 1999 Nov; 461(1-2):91-5. PubMed ID: 10561502
[TBL] [Abstract][Full Text] [Related]
10. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
Dawson HN; Cantillana V; Chen L; Vitek MP
J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
[TBL] [Abstract][Full Text] [Related]
11. Hereditary frontotemporal dementia caused by Tau gene mutations.
van Swieten J; Spillantini MG
Brain Pathol; 2007 Jan; 17(1):63-73. PubMed ID: 17493040
[TBL] [Abstract][Full Text] [Related]
12. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells.
Vogelsberg-Ragaglia V; Bruce J; Richter-Landsberg C; Zhang B; Hong M; Trojanowski JQ; Lee VM
Mol Biol Cell; 2000 Dec; 11(12):4093-104. PubMed ID: 11102510
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation.
Delobel P; Flament S; Hamdane M; Jakes R; Rousseau A; Delacourte A; Vilain JP; Goedert M; Buée L
J Biol Chem; 2002 Mar; 277(11):9199-205. PubMed ID: 11756436
[TBL] [Abstract][Full Text] [Related]
14. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations.
Alonso Adel C; Mederlyova A; Novak M; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2004 Aug; 279(33):34873-81. PubMed ID: 15190058
[TBL] [Abstract][Full Text] [Related]
15. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
16. Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Matsumura N; Yamazaki T; Ihara Y
Am J Pathol; 1999 Jun; 154(6):1649-56. PubMed ID: 10362789
[TBL] [Abstract][Full Text] [Related]
17. The effect of tau genotype on clinical features in FTDP-17.
Baba Y; Tsuboi Y; Baker MC; Uitti RJ; Hutton ML; Dickson DW; Farrer M; Putzke JD; Woodruff BK; Ghetti B; Murrell JR; Boeve BF; Petersen RC; Verpillat P; Brice A; Delisle MB; Rascol O; Arima K; Dysken MW; Yasuda M; Kobayashi T; Sunohara N; Komure O; Kuno S; Sperfeld AD; Stoppe G; Kohlhase J; Pickering-Brown S; Neary D; Bugiani O; Wszolek ZK
Parkinsonism Relat Disord; 2005 Jun; 11(4):205-8. PubMed ID: 15878580
[TBL] [Abstract][Full Text] [Related]
18. Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients.
Rizzu P; Joosse M; Ravid R; Hoogeveen A; Kamphorst W; van Swieten JC; Willemsen R; Heutink P
Hum Mol Genet; 2000 Dec; 9(20):3075-82. PubMed ID: 11115852
[TBL] [Abstract][Full Text] [Related]
19. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.
Nacharaju P; Lewis J; Easson C; Yen S; Hackett J; Hutton M; Yen SH
FEBS Lett; 1999 Mar; 447(2-3):195-9. PubMed ID: 10214944
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic variation in hereditary frontotemporal dementia with tau mutations.
van Swieten JC; Stevens M; Rosso SM; Rizzu P; Joosse M; de Koning I; Kamphorst W; Ravid R; Spillantini MG; Niermeijer ; Heutink P
Ann Neurol; 1999 Oct; 46(4):617-26. PubMed ID: 10514099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
